Read this company snapshot
Daily valuation snapshot
Integer Holdings Corporation: source evidence dated 2026-10-09.
- Daily close (USD)
- $126.61
- Market capitalization (USD)
- $4,303,733,197.28
- Price / earnings (TTM)
- Not reported
- Price / book
- 2.5
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research ITGR in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research ITGR in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. The company was founded in 1970 and is headquartered in Plano, Texas.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing ITGR with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $126.61 |
| Market capitalization (USD) | $4,303,733,197.28 |
| Price / earnings (TTM) | Not reported |
| Price / book | 2.5 |
No matching rows. Clear the filter to see all records.
Read ITGR's valuation metrics
Company size
Integer Holdings Corporation's recorded market capitalization is $4,303,733,197.28. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
ITGR's recorded price-to-book ratio is 2.5. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Integer Holdings Corporation with Aurora
Use the snapshot above to ask a specific question about ITGR. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow ITGR's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.